Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Baerends, Eva A. M."'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Hvidt, Astrid K., Baerends, Eva A. M., Søgaard, Ole S., Stærke, Nina B., Raben, Dorthe, Reekie, Joanne, Nielsen, Henrik, Johansen, Isik S., Wiese, Lothar, Benfield, Thomas L., Iversen, Kasper K., Mustafa, Ahmed B., Juhl, Maria R., Petersen, Kristine T., Ostrowski, Sisse R., Lindvig, Susan O., Rasmussen, Line D., Schleimann, Marianne H., Andersen, Sidsel D., Juhl, Anna K., Dietz, Lisa L., Andreasen, Signe R., Lundgren, Jens, Østergaard, Lars, Tolstrup, Martin
Publikováno v:
Hvidt, A K, Baerends, E A M, Søgaard, O S, Stærke, N B, Raben, D, Reekie, J, Nielsen, H, Johansen, I S, Wiese, L, Benfield, T L, Iversen, K K, Mustafa, A B, Juhl, M R, Petersen, K T, Ostrowski, S R, Lindvig, S O, Rasmussen, L D, Schleimann, M H, Andersen, S D, Juhl, A K, Dietz, L L, Andreasen, S R, Lundgren, J, Østergaard, L & Tolstrup, M 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in Medicine, vol. 9, 994160 . https://doi.org/10.3389/fmed.2022.994160
Hvidt, A K, Baerends, E A M, Søgaard, O S, Stærke, N B, Raben, D, Reekie, J, Nielsen, H, Johansen, I S, Weise, L, Benfield, T L, K. Iversen, K, B. Mustafa, A, Juhl, M R, Petersen, K T, Ostrowski, S R, Lindvig, S O, Rasmussen, L D, Schleimann, M H, Andersen, S D, Juhl, A K, Dietz, L L, R. Andreasen, S, Lundgren, J, Østergaard, L, Tolstrup, M & the ENFORCE Study Group 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in Medicine, vol. 9, 994160 . https://doi.org/10.3389/fmed.2022.994160
Hvidt, A K, Baerends, E A M, Søgaard, O S, Stærke, N B, Raben, D, Reekie, J, Nielsen, H, Johansen, I S, Wiese, L, Benfield, T L, Iversen, K K, Mustafa, A B, Juhl, M R, Petersen, K T, Ostrowski, S R, Lindvig, S O, Rasmussen, L D, Schleimann, M H, Andersen, S D, Juhl, A K, Dietz, L L, Andreasen, S R, Lundgren, J, Østergaard, L, Tolstrup, M & the ENFORCE Study Group 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in medicine, vol. 9, 994160 . https://doi.org/10.3389/fmed.2022.994160
ENFORCE Study Group 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in medicine, vol. 9, pp. 994160 . https://doi.org/10.3389/fmed.2022.994160
Hvidt, A K, Baerends, E A M, Søgaard, O S, Stærke, N B, Raben, D, Reekie, J, Nielsen, H, Johansen, I S, Weise, L, Benfield, T L, K. Iversen, K, B. Mustafa, A, Juhl, M R, Petersen, K T, Ostrowski, S R, Lindvig, S O, Rasmussen, L D, Schleimann, M H, Andersen, S D, Juhl, A K, Dietz, L L, R. Andreasen, S, Lundgren, J, Østergaard, L, Tolstrup, M & the ENFORCE Study Group 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in Medicine, vol. 9, 994160 . https://doi.org/10.3389/fmed.2022.994160
Hvidt, A K, Baerends, E A M, Søgaard, O S, Stærke, N B, Raben, D, Reekie, J, Nielsen, H, Johansen, I S, Wiese, L, Benfield, T L, Iversen, K K, Mustafa, A B, Juhl, M R, Petersen, K T, Ostrowski, S R, Lindvig, S O, Rasmussen, L D, Schleimann, M H, Andersen, S D, Juhl, A K, Dietz, L L, Andreasen, S R, Lundgren, J, Østergaard, L, Tolstrup, M & the ENFORCE Study Group 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in medicine, vol. 9, 994160 . https://doi.org/10.3389/fmed.2022.994160
ENFORCE Study Group 2022, ' Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines ', Frontiers in medicine, vol. 9, pp. 994160 . https://doi.org/10.3389/fmed.2022.994160
The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed to protect against severe disease, hospitalization and death. In the prese
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ee047f48c84d042bd9800b64d22849
https://curis.ku.dk/portal/da/publications/comparison-of-vaccineinduced-antibody-neutralization-against-sarscov2-variants-of-concern-following-primary-and-booster-doses-of-covid19-vaccines(117ce3db-e206-412e-a3d4-fc1ae068b06c).html
https://curis.ku.dk/portal/da/publications/comparison-of-vaccineinduced-antibody-neutralization-against-sarscov2-variants-of-concern-following-primary-and-booster-doses-of-covid19-vaccines(117ce3db-e206-412e-a3d4-fc1ae068b06c).html